I wouldn't mind AHZ taking over ACG adding strength to the BP side of the med supplies business.
ACG is making changes to its take-over thingys inits constitution.
The director appointments have a BP side to their story.
The chair at ACG is getting close to retiring.
I wouldn't mind getting more AHZ stock via a T/O, doubt it'll happen though.
http://f7c7d424d952e13b4dbb-e9c4b54...loads/sites/4/2013/10/233_Tango_Plus_2011.pdf
Ann: Admedus to showcase CardioCel at EACTS Annual Meeting, page-55
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |